PR104 and G-CSF in Treating Patients With Solid Tumors

NCT00616213 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: filgrastim
DRUG: PR104
OTHER: F-18-fluoromisonidazole

Sponsor

Proacta, Incorporated